Showing results (121-130 of 282) with videos related to
Sort By:
Pageof 29
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantationOlga Sala-Torra, Colleen Hanna, Michael R Loken, et al.Journal of Pediatric Hematology/Oncology|June 29, 2016
Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase IntoleranceKee K Yeo, Paul S Gaynon, Cecilia H Fu, et al.Toxins|June 9, 2018
Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic LeukemiaFabian Müller, Tyler Cunningham, Richard Beers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Thromboembolic events in children and young adults with pediatric sarcomaIdo Paz-Priel, Lauren Long, Lee J Helman, et al.British Journal of Haematology|November 29, 2014
Abnormal bone marrow histopathology in paediatric mastocytosisMelody C Carter, Dean D Metcalfe, Alicia S Clark, et al.Leukemia|January 23, 2026
Next-generation sequencing from chronic myeloid leukemia dried blood spots: insights and implications for global oncologyVivian G Oehler, Olga Sala-Torra, Neta Gilderman, et al.Haematologica|July 23, 2026
Personalized measurable residual disease assays for acute myeloid leukemia guided by whole-genome sequencingNiveditha Ravindra, Rasha W Al-Ali, Justin Lack, et al.Blood|July 13, 2013
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remissionRoland B Walter, Sarah A Buckley, John M Pagel, et al.Leukemia|October 4, 2023
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemiaNicholas C P Cross, Thomas Ernst, Susan Branford, et al.Blood|March 24, 2009
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.Pageof 29